Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
The peri/postoperative analgesic effect of intravenous paracetamol in dogs
Mckay L.
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Read
PICO question
In healthy dogs undergoing a surgical procedure, is there improved pain control in dogs receiving intravenous paracetamol in the peri / postoperative period compared to dogs not receiving intravenous paracetamol?
Appraisal, application and reflection
In the UK, a product containing paracetamol and codeine is licensed in dogs as an oral formulation (Pardale- VTM). In particular, 33 mg/kg of paracetamol and 0.75 mg/kg codeine repeated every 8 hours can be administered to dogs for up to 5 days. In dogs undergoing different types of surgeries, the postoperative analgesic effect of a paracetamol-codeine administered every 8 hours was not inferior to meloxicam (Pacheco et al., 2020). The aforementioned studies in the summary of evidence utilise a human formulation of intravenous paracetamol. There is no veterinary licensed equivalent.
According to the BSAVA Formulary (BSAVA, 2020), paracetamol should be administered at 10–20 mg/kg intravenously (IV). While a pharmacokinetic study was performed using this dose range in Beagle and Galgo español dogs, the variable therapeutic range observed between the two dog breeds made the authors conclude that further investigations were warranted to better understand the paracetamol pharmacokinetic properties in the context of anti-nociception in dogs (Serrano-Rodríguez et al., 2019).
Despite that the results of Hernández-Avalos et al. (2020) and Leung et al. (2021) appear to contradict each other, the methodology used makes a comparison between them difficult. Both of them are blinded, randomised, controlled studies, and they tried to address the PICO question in relation to the postoperative analgesic efficacy of paracetamol. In both studies, dogs undergoing ovariohysterectomies were used. Still, the intraoperative analgesic technique employed was different and could have affected the level of postoperative pain and, therefore, the effectiveness of paracetamol. While in Leung et al. (2021), preoperative pethidine was administered as an analgesic, a fentanyl constant rate infusion was used by Hernández-Avalos et al. (2020).
Pethidine is a synthetic opioid and has been shown to provide a dose-dependent effect in dogs, with 3.5 mg/kg intramuscularly (IM) providing 90 minutes of analgesia (Waterman & Kalthum, 1989). According to Lascelles et al. (1997), pethidine (5 mg/kg IM) is an effective but short-acting analgesic in dogs undergoing ovariohysterectomy. Vettorato & Bacco (2011) showed that pethidine (5 mg/kg IM) produced postoperative analgesia up to 4 hours in dogs undergoing ovariectomy or ovariohysterectomy.
The study from Hernández-Avalos et al. (2020), a perioperative fentanyl constant rate infusion (5 mg/kg/hr IV) was administered. Fentanyl is a potent, short-acting opioid and has been shown to provide adequate analgesia in dogs undergoing ovariohysterectomies at 10 mg/kg/hr IV (Gutierrez-Blanco et al., 2015). According to De Moura et al. (2022), fentanyl infusions at 5 mg/kg/hr IV provided adequate peri and postoperative analgesia in dogs undergoing surgical mastectomies. The quality of perioperative analgesia was considered ‘good’ in dogs receiving fentanyl at 4 mg/kg/hr IV while undergoing orthopaedic surgery, although rescue analgesia was required in 4/8 (50%) of cases (Bufalari et al., 2007).
The study by Leung et al. (2021) did not find a statistical difference between paracetamol (20 mg/kg IV) and saline. However, the study was terminated prematurely. Considering the results obtained (rescue analgesia was needed in 4/7 (57.1%) of dogs in the paracetamol group and 6/7 (85.7%) of dogs in group saline), at least 40 dogs per group would have been required to prove the superiority of paracetamol. Furthermore, paracetamol was administered postoperatively. It is unknown if its preoperative administration, at 20 mg/kg or higher doses, would have produced a better postoperative analgesic effect. However, it is probable that paracetamol alone is not a very effective analgesic in dogs undergoing ovariohysterectomy.
The pre-emptive administration of paracetamol, even at a lower dose (15 mg/kg IV), might be responsible for the better postoperative analgesia reported by Hernández-Avalos et al. (2020). This study concluded that the effect of paracetamol is equivalent to that of meloxicam and carprofen. However, plasma concentrations were not analysed. According to Leung et al. (2021), 40 minutes after the IV administration of paracetamol (20 mg/kg), its plasmatic concentration was < 10 µg/ml in all dogs. This is well below the plasma concentration that provides analgesia in humans (Gibb & Anderson, 2008; and Brett et al., 2012). Therefore, more research is warranted to better characterise the optimal dose and the analgesic activity of paracetamol in dogs. The two clinical studies used different methods to assess pain. The Hernández-Avalos et al. (2020) study used the Dynamic Interactive Visual Analogue Scale (DIVAS) and the University of Melbourne Pain Scale (UMPS), both of which are non-validated in the dog. In contrast, Leung et al. (2021) used the Short Form Glasgow Composite Pain Scale, which is a multi-item behavioural pain assessment tool developed and validated using a psychometric approach in the dog (Reid et al., 2007).
In Hernández-Avalos et al. (2020) study, one individual performed all the assessments, but it is impossible to rule out if one scale influenced the results of the second one. Therefore, both studies should be interpreted with caution.
The third study outlined in this summary (González-Blanco et al., 2020) is a well-designed study which also used a 15 mg/kg paracetamol dose similar to the Hernández-Avalos et al. (2020) study. A plasma sample was obtained 2 minutes after the administration of paracetamol and approximately 2 hours later. Similarly to Leung et al. (2021), the plasma concentrations of paracetamol falls below therapeutic levels 2 hours after its administration. The baseline minimum alveolar concentration (MAC) value of sevoflurane was determined 20 minutes post-induction of anaesthesia (MAC1), and a second MAC value (MAC2) was determined 2–2.5 hours after paracetamol or saline administration. While the MAC2 value of the paracetamol group was 15% lower than the control group, it was identical to MAC1. Instead, in the saline group, MAC2 was 15% higher than MAC1. Therefore, the difference found was not deemed clinically significant by the authors. The results of this study might be affected by the small sample size, by the use of propofol as an induction agent that could have affected MAC1 measurements, and the fact that the therapeutic plasmatic concentrations of paracetamol were potentially too low for the type of noxious stimulus applied to determine MAC2. Furthermore, this study is less relevant to the PICO question as it does not evaluate postoperative analgesia but an anti-nociceptive effect.
Despite many drugs having a MAC-sparing effect without inducing analgesia (i.e. acepromazine), analgesic drugs can have analgesic effects without producing a clinically relevant MAC-sparing effect (i.e. NSAIDs) (Reed & Doherty, 2018). According to Yamashita et al. (2008), a reduction of MAC was demonstrated by carprofen and meloxicam by 11% and 13%, respectively, similar to what was reported by González-Blanco et al. (2020).
All three reviewed studies reported no adverse side effects after a single IV paracetamol injection. In particular, Hernández-Avalos et al. (2020) did not report any change in cardiorespiratory, liver and renal parameters up to 48 hours postoperatively following 8 hourly continued IV paracetamol administered in healthy dogs. However, toxic side effects, including depression, weakness, recumbency and methaemoglobinaemia, were observed following the administration of a single dose of 150 mg/kg IV of paracetamol in dogs (St. Omer & Mohammad, 1984). While paracetamol (15–20 mg/kg IV) seems to be safe in healthy dogs, further research is required to fully evaluate its real analgesic effect, the dose at which it should be used, and the potential side effects caused by repetitive administration in both healthy and non-healthy dogs.
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
About
Affiliation of the authors at the time of publication
The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush Campus, Midlothian, EH25 9RG
* Corresponding author email: [email protected]
Copyright Statement
© All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.Related Content
Readers also viewed these publications
Subscribe
Veterinary Evidence is an online, open access, peer-reviewed journal owned and published by RCVS Knowledge. If you would like to receive updates on recent publications, you can register here. If you would like to submit an manuscript for publication in the Veterinary Evidence journal, you can consult the Guidelines for Authors.
Comments (0)
Ask the author
0 comments